IMMUNE CHECKPOINT INHIBITOR SALVAGE THERAPY IN PATIENT WITH REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA. Voprosy onkologii, v. 65, n. 2, p. 294–297, 1 Feb.2019.